SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-22-264457
Filing Date
2022-10-18
Accepted
2022-10-18 16:13:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d412521dsc14d9.htm SC 14D9 554019
2 GRAPHIC g412521g00a01.jpg GRAPHIC 28449
  Complete submission text file 0001193125-22-264457.txt   591623
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filed by) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-90696 | Film No.: 221316126
SIC: 2836 Biological Products, (No Diagnostic Substances)